Projects per year
- 100 - 150 out of 502 results
Search results
-
A Study to Assess the Antitumor Activity and Safety of IMAB362 in Combination With Nab-Paclitaxel and Gemcitabine (Nab-P + GEM) as First Line Treatment in Subjects With Claudin 18.2 (CLDN18.2) Positive, Metastatic Pancreatic Adenocarcinoma
Abdelrahim, M., Chang, J. C., Heyne, K., Niravath, P. A., Singh, M. & Zhang, J.
5/2/22 → …
Project: Clinical Trial
-
Atheroprotection via Reduced Plasma High Density Lipoprotein-Free Cholesterol Bioavailability
Pownall, H. J., Rosales, C. & Gillard, B. K.
12/1/19 → 11/30/24
Project: Federal Funding Agencies
-
BI 1425-0003 - Phase IIa - Crohn's Study - A Phase IIa, randomised, double-blind, placebo-controlled trial to evaluate the safety, efficacy, pharmacokinetics and pharmacodynamics of BI 706321 orally administered for 12 weeks in patients with Crohn`s Disease (CD) receiving ustekinumab induction treatment
Abraham, B. P., Fan, C. & Glassner, K.
10/3/22 → …
Project: Clinical Trial
-
Bioenergetic potentiation in Alzheimer's Disease as a therapeutic strategy
2/1/22 → 1/31/25
Project: Non Profit
-
-
Biophysical roles of pre-metastatic niche evolution on transport of circulating tumor cells
2/15/20 → 1/31/25
Project: Federal Funding Agencies
-
Brain structural and functional changes underlying post-stroke depression
9/20/22 → 8/31/24
Project: Federal Funding Agencies
-
CAPTIVA- Comparison of Anti-coagulation and anti-Platelet Therapies for Intracranial Vascular Atherostenosis
9/1/21 → 8/31/26
Project: Federal Funding Agencies
-
Capturing the genomic variation present in Cryptosporidium and cryptosporidiosis
4/1/22 → 7/31/24
Project: Federal Funding Agencies
-
Cardiac Autonomic Activation In Atrial Fibrillation Triggers And Substrate
4/1/23 → 3/31/28
Project: Federal Funding Agencies
-
Cardiogenic Shock Working Group Registry
Kim, J. H., Bhimaraj, A., Fida, N., Guha, A., Hussain, I., Kassi, M. & Yousefzai, R.
10/1/21 → …
Project: Clinical Trial
-
Cardiovascular Disease Health System Registry
Nasir, K., Jones, S. L., Lador, A., Patel, K. V. & Vahidy, F. S.
11/16/21 → …
Project: Clinical Trial
-
Carotid Revascularization and Medical Management for Asymptomatic Carotid stenosis - Hemodynamics (CREST-H)
Chiu, D., Gadhia, R. R., Misra, V. & Volpi, J. J.
5/15/17 → 7/31/27
Project: Federal Funding Agencies
-
CAROTID REVASCULARIZATION AND MEDICAL MANAGEMENT FOR ASYMPTOMATIC CAROTID STENOSIS TRIAL (CREST-2) PROTOCOL
Chiu, D., Diaz, O. M., Gadhia, R. R., Klucznik, R. P., Lumsden, A. B., Shah, A. R. & Volpi, J. J.
3/1/15 → 8/31/24
Project: Federal Funding Agencies
-
Central and peripheral immune cross-talk in Alzheimer's disease and their modulation by a novel immunotherapy
1/1/23 → 12/31/25
Project: Federal Funding Agencies
-
Cephea Early Feasibility Study
Goel, S., Faza, N., Kleiman, N., Little, S. H., Reardon, M. J. & Yousefzai, R.
7/28/22 → …
Project: Clinical Trial
-
Changes in cardiac nerve activity during apnea in atrial fibrillation patients
Valderrábano, M., Dave, A., Mathuria, N. & Schurmann, P. A.
7/1/21 → …
Project: Clinical Trial
-
-
Chemoprevention of lung cancer by targeting lonidamine to mitochondria
9/1/21 → 8/31/24
Project: Federal Funding Agencies
-
Chemoprevention with mitochondria-targeted honokiol in mouse models of lung cancer: adenocarcinoma and squamous cell carcinoma
9/15/22 → 9/14/25
Project: Federal Funding Agencies
-
-
Circulating Proteomics to Phenotype the Development and Reversal of Myocardial Remodeling in Aortic Stenosis
4/1/23 → 1/31/27
Project: Federal Funding Agencies
-
Clazakizumab - COVID-19
Huang, H. J., Gaber, A. O., Goodarzi, A., Graviss, E. A., Moore, L. W., Yau, S. W. & Youssef, J. G.
7/8/20 → …
Project: Clinical Trial
-
-
-
CMR for COVID Patients
Shah, D. J., Graviss, E. A., Malahfji, M. & Nasir, K.
6/16/20 → …
Project: Clinical Trial
-
Collaborative Research: FW-HTF-RM: Robotic Teaching Assistant Systems for Nursing Instructors
11/1/23 → 10/31/27
Project: Federal Funding Agencies
-
Colorectal Cancer Metastatic dMMR Immuno-Therapy (COMMIT) Study:A Randomized Phase III Study of mFOLFOX6/Bevacizumab Combination Chemotherapy with orwithout Atezolizumab or Atezolizumab Monotherapy in the First-Line Treatment of Patients withDefici
Abdelrahim, M., Bernicker, E. H., Darcourt, J., Heyne, K. & Singh, M.
3/1/14 → 2/28/39
Project: Non Profit
-
Combining Transcutaneous Spinal Stimulation and Exoskeleton Training in the Rehabilitation of Spinal Cord Injury.
Sayenko, D., Kaldis, T. & Tabatabai, L. S.
6/20/22 → …
Project: Clinical Trial
-
Comparative effectiveness randomized clinical trial to assess the clinical efficacy of VE when used in combination with RF ablation compared with RF ablation alone -Venous Ethanol for Left Ventricular Ischemic Ventricular Tachycardia -VELVET clinical trial
Valderrábano, M., Dave, A., Lador, A., Mathuria, N. & Schurmann, P. A.
6/6/23 → …
Project: Clinical Trial
-
CONNECT-AV Post-Market Surveillance of WavelinQ EndoAVF System BD Bard
4/4/22 → …
Project: Clinical Trial
-
Contemporary Classification of Myocardial Injury Events in MESA: Defining Distinct Risk Factor Associations with Myocardial Infarction Type 1-5 and Acute Non-Ischemic Myocardial Injury.
8/20/21 → 7/31/26
Project: Federal Funding Agencies
-
-
Convergent AI for Precise Breast Cancer Risk Assessment
Wong, S. T., Chang, J. C. & Ensor, Jr., J. E.
6/1/20 → 5/31/25
Project: Federal Funding Agencies
-
Corrona Inflammatory Bowel Disease (IBD) Registry
Abraham, B. P., Fan, C. & Glassner, K.
4/3/18 → …
Project: Clinical Trial
-
-
-
-
-
CPS: Medium: Collaborative Research: Wireless Magnetic Millibot Blood Clot Removal and Navigation in 3-D Printed Patient-Specific Phantoms using Echocardiography
9/15/19 → 8/31/24
Project: Federal Funding Agencies
-
CTSU - IRB SUBMISSIONA Phase III Trial To Evaluate The Efficacy Of The Addition Of Inotuzumab Ozogamicin (A Conjugated Anti-Cd22 Monoclonal Antibody) To Frontline Therapy In Young Adults (Ages 18-39 Years) With Newly Diagnosed Precursor B-Cell ALL.
Abdelrahim, M., Bernicker, E. H., Chang, J. C., Heyne, K., Niravath, P. A., Singh, M. & Zhang, J.
3/6/20 → 3/5/45
Project: Non Profit
-
-
CY 6022-Open-Label Study of CK-3773274 for Patients with oHCM Cytokinetics
Nagueh, S., Buergler, J., Kurrelmeyer, K. M. & Nabi, F.
5/19/22 → …
Project: Clinical Trial
-
CY 6031 Phase 3 - To Evaluate CK3773274 in patients with oHCM, LVOT Cytokinetics, Inc.
Nagueh, S., Buergler, J., Chamsi-Pasha, M. A. & Kurrelmeyer, K. M.
8/10/22 → …
Project: Clinical Trial